Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

Proposed Medicaid cuts could threaten lifesaving HIV treatment access, warns Avenue 360. HOUSTON — With President Trump's " ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...

A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

WASHINGTON — Senate Republicans on Tuesday advanced President Donald Trump's request to cancel some $9 billion in previously ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Aurobindo Pharma to manufacture and supply long-acting injectable HIV treatment in 133 countries, offering alternative to ...